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Abstract
Background: Menstrual cycle-related symptoms are an important health issue for many women, and some may
affect cardiac autonomic regulation. In the present study, we evaluated the cardiovascular and physiological stress
response to 12-h short-term fasting in the menstrual phases of healthy young women.
Methods: We performed a randomized crossover study. Subjects were seven female university students
(age: 22.3 ± 1.0 years). The experiments comprised four sessions: meal intake in the follicular phase, meal intake in the
luteal phase, fasting in the follicular phase, and fasting in the luteal phase. All subjects participated in a total of four
experimental sessions during two successive phases (follicular and luteal phase in the same menstrual cycle, or luteal
phase and follicular phase in the next menstrual cycle) according to a randomized crossover design. R-R intervals were
continuously recorded before and after meals, and power spectral analysis of heart rate variability was performed.
Other physiological data were obtained before and 20, 40, 60, and 80 min after meal intake or after the corresponding
time point of meal intake (fasting in the follicular or luteal phase).
Results: Heart rate decreased during fasting in the follicular and luteal phases. High frequency power increased during
fasting in the follicular and luteal phases. In addition, salivary cortisol concentrations decreased during fasting in the
luteal phase.
Conclusions: In the present study, short-term fasting resulted in higher parasympathetic activity and lower cortisol
levels in the luteal phase in these young women. These results indicate a possibility to produce an anti-stress effect in
the luteal phase, which may reduce menstrual symptoms.
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Background
Menstrual cycle-related symptoms may include psycho-
logical symptoms, such as irritation or depressed feelings,
or physical symptoms, such as headache or stomach ache
in the premenstrual [1–3] and menstrual phases of the
menstrual cycle [4, 5]. According to the estimation of
World Health Organization (WHO), 199 million women
had premenstrual syndrome as of 2010, which was 5.8 % of
all women [6]. Previous reports also showed about 10 % of
women had premenstrual syndrome, and about 70–90 %
of women experienced menstrual cycle-related symptoms
[7–13]. This also applies to Japanese women [14–16]. In
addition to physiological characteristics, menstrual cycle-
related symptoms affect health-related quality of life [17].
According to an epidemiological study, average scores of
students with premenstrual syndrome were significantly
lower in all domains of quality of life [18, 19]. Therefore,
alleviation of these symptoms is expected to contribute to
improvement of quality of life.
Previous studies showed that symptoms are severe
during the luteal phase [11, 20, 21]. The venous oxygen-
ation index is decreased in the late luteal phase in pre-
menstrual syndrome subjects [22]. In addition, stressful
situations have been reported to be associated with the
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occurrence of menstrual cycle-related symptoms [23].
Stress is known to affect cardiovascular changes, which
are usually related to autonomic nervous system activity
changes [24]. Spectral analysis of heart rate variability
(HRV) provides a sensitive, non-invasive measure of car-
diac autonomic regulation. Two main frequency compo-
nents of HRV have been demonstrated, low frequency
(LF: 0.04–0.15 Hz) reflecting both sympathetic and para-
sympathetic nervous system activity, and high frequency
(HF: 0.15–0.40 Hz) reflecting the activity of the parasym-
pathetic nervous system [25]. Consequently, the LF-to-HF
(LF/HF) ratio represents the sympathovagal balance [25].
In previous studies, HF was lower in the luteal phase than
the follicular phase [26–31], and LF/HF was higher in the
luteal phase than the follicular phase [26–29, 32], indicat-
ing increased sympathetic nervous activity in the luteal
phase and increased parasympathetic nervous activity in
the follicular phase. Moreover, sympathetic nervous activ-
ity is stronger in women with severe menstrual symptoms
than in those with less severe symptoms [33].
Dietary restriction (DR), also known as calorie restric-
tion, is a restriction of total food from ad libitum feeding.
There is some evidence that restricting single micronutri-
ents or organic compounds, such as sodium or caffeine,
alleviates menstrual cycle-related symptoms [34, 35].
Pellizzer et al. reported that reduced dietary fat intake in-
creased parasympathetic activity in women [36]. Fasting is
one form of DR. The anti-stress effects of fasting were
demonstrated in men, whereby short-term fasting (12 h)
increased parasympathetic domain activity while meal in-
take activated sympathetic domain activity [37]. However,
there is little evidence of the anti-stress effects of short-
term fasting on menstrual cycles. Some studies reported
that 2.5- to 3.5-day fasting suppresses the reproductive
axis [38–40], which means a fasting period is critical. All
of these factors lead us to hypothesize that 12-h short-
term fasting may increase parasympathetic activity in the
luteal phase.
Therefore, in the present study, we evaluated the car-
diac autonomic regulation and physiological stress re-
sponse to 12-h short-term fasting during each menstrual
phase in young women.
Methods
Subjects
The subjects were recruited from the local university
with no incentives. We enrolled seven healthy female
students who satisfied the inclusion and exclusion cri-
teria for entry into the study. The inclusion criteria were
female gender and age of 20 to 24 years. The exclusion
criteria were past and current smoking, alcoholism,
high-performance athletes, medication use, oral contra-
ceptive use, irregularity of menstrual cycle, parity, and
body mass index ≥ 25 kg/m2. All subjects were carefully
informed about the purpose and potential risks of this ex-
periment, and all gave written informed consent to partici-
pate in this study. The study protocol was approved by the
Human Ethics Committee of the Graduate School of
Human Development and Environment, Kobe University.
Experimental procedure
The experiments were conducted from February 2012 to
February 2014. The experimental procedure is shown in
Fig. 1a and b. All subjects participated in a total of four ex-
perimental sessions during two successive phases (follicular
and luteal phase in the same menstrual cycle, or luteal
phase and follicular phase in the next menstrual cycle) ac-
cording to a randomized crossover design. In the first men-
strual cycle, the first and second sessions were conducted.
In the second menstrual cycle, the third and fourth sessions
were conducted. In the first and second sessions in the first
menstrual cycle, the subjects were randomly assigned to
each trial: (1) the meal intake trial or (2) the fasting trial.
After a 12-h overnight fast, subjects assigned to the meal
intake trial were served a test meal, and those assigned to
the fasting trial continued fasting for a further 2 h (total
14 h). If the first session was conducted in the follicular
phase, the second session was conducted in the luteal phase
in the same menstrual cycle. If the first session was con-
ducted in the luteal phase, the second session was con-
ducted in the follicular phase in the next menstrual cycle.
Third and fourth sessions were also conducted in the same
way as the first and second sessions. In the first and second
sessions, the subjects were randomly assigned to the meal
intake trial or the fasting trial. In the third and fourth ses-
sion, the subjects were assigned to other than the trial
assigned in each follicular or luteal phase in the first and
second sessions. Subjects were determined as being in the
follicular phase or luteal phase based on the occurrence of
menstruation and ovulation. Ovulation was recognized by a
surge in luteinizing hormone detected using two self-
examination kits for luteinizing hormone (L-check FT;
Nipro Co., Ltd, Osaka, Japan and P-check; Mizuho Medy
Co., Ltd, Saga, Japan).
On the day before testing, the subjects in both the
meal intake trial and the fasting trial finished their meals
by 21:00 h and went to sleep before 24:00 h. They
abstained from drinks containing caffeine, food contain-
ing capsaicin, alcohol, and sports activity for 24 h prior
to each testing day. After overnight fasting, each subject
arrived at the laboratory between 08:00 h and 08:30 h
and rested in the supine position for 20 min in an environ-
mentally controlled room (temperature, 23–26 °C; relative
humidity, 50–60 %). After resting, baseline physiological
and psychological assessments were conducted. Saliva
samples were collected at the same time, and stored at
−25 °C for assessment of salivary cortisol levels. The
physiological assessments included an electrocardiogram,
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and measurement of systolic blood pressure (SBP) and
diastolic blood pressure (DBP). SBP and DBP were mea-
sured by the Riva-Rocci-Korotkoff method using a digital
manometer (GP-303S, Parama-Tech Co., Ltd, Fuku-
oka, Japan). A test meal was served for the meal in-
take trial at 09:50 h, and the subjects finished eating
by 10:05 h. Postprandial physiological and psycho-
logical data and a saliva sample were obtained at 20,
40, 60, and 80 min after meal intake. For the fasting
trial, a test meal was not served, but physiological
and psychological data and a saliva sample were ob-
tained 20, 40, 60, and 80 min after the corresponding
time point of intake of food in the meal intake trial.
Composition of nutrients and energy content in each trial
The meal for the experiment consisted of 81 g of bread
made from bread flour and white sugar, 26 g of ham, and
200 g of orange juice, which together contained 395 kcal
of energy, 15.5 g of protein, 11.3 g of fat, 57.5 g of carbo-
hydrate (energy %: protein/carbohydrate/fat 15/62/23),
and 0.8 g of sodium. The overall energy contained in the
meal and the energy proportions of carbohydrate, protein,
and fat were determined according to the mean intake of
food in females in their 20s reported in the National Nu-
trient Survey in Japan [41]. These meals were served at
36.0 °C. Meal temperature was measured using a non-
contact thermometer (Thermo-Hunter, model PT-2LD;
Optex Co., Otsu, Japan). All drinks were provided at room
temperature. In the fasting trial, each subject continued
fasting throughout the experiment for a further 2 h.
Heart rate variability
The R-R intervals, the time interval between two con-
secutive R waves in the electrocardiogram, were con-
tinuously recorded before and after meals by an
ambulatory electrocardiograph monitor (Active Tracer
AC-301A; GMS Inc., Tokyo, Japan) with a sampling
rate of 1 kHz. Power spectral analysis of HRV was per-
formed using a 16th-order autoregressive model [42] by
Kubios HRV analysis software 2.0 (Biomedical Signal
and Medical Imaging Analysis Group, Department of
Applied Physics, University of Kuopio, Finland) [43].
We analyzed low frequency power (LF: 0.04–0.15 Hz)
and high frequency power (HF: 0.15–0.40 Hz) as HRV
parameters. LF power reflects sympathetic and parasym-
pathetic modulation of the heart, whereas HF power pri-
marily reflects parasympathetic modulation of the heart
[25]. LF and HF power were computed for each minute of
the 5-min R-R data [44]. The LF/HF ratio was calculated as
an index of sympathovagal balance [25]. The mean of each
1-min HRV was used for statistical analysis.
Salivary cortisol assay
All frozen samples were thawed, mixed, and centri-
fuged at 3000 × g for 10 min at room temperature.
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Fig. 1 Experiment design. a Session and menstrual phase. Subjects were randomly assigned to the follicular session or luteal session. The second
session was conducted in the other menstrual phase of the first session. Third and fourth sessions were conducted as well as the first and second
session. In the first and second session, the subjects were randomly assigned to the meal intake trial or the fasting trial. In the third and fourth
session, the subjects were assigned to the other trial. In each session, baseline and subsequent measurements were conducted. Baseline and
skew-patterned square in each session shows 12-h fasting. b Experiment procedure in each session. MB baseline measurement, M20 measurement
at 20 min after meal intake, M40 measurement at 40 min after meal intake, M60 measurement at 60 min after meal intake, M80 measurement at
80 min after meal intake, MI/F meal intake in the meal intake trial or fasting in the fasting trial
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immunoassay specifically validated for the quantitative
measurement of salivary cortisol (Salimetrics LLC,
State College, PA, USA). The calibration range was
0.012–3.0 μg/dL.
Statistical analysis
Data are shown as means ± standard error. The Student’s
t test was used to detect differences between the trials at
baseline. A two-way repeated-measures analysis of vari-
ance (ANOVA) was used to investigate the effects of
meal conditions (eating or fasting), the effects of time,
and interaction effects between condition and time on
physiological parameters. The Bonferroni test was used
for post-hoc analysis. Effect sizes are reported as general-
ized eta squared (ηG
2 ), which allows direct comparison of
within- and between-subjects designs [45], and inter-
preted according to Cohen’s recommendation of .02 for
a small effect, .13 for a medium effect, and .26 for a large
effect [46]. Statistical analysis was performed using SPSS
Statistics 19 (IBM Inc., Tokyo, Japan). A P value less
than 0.05 was considered statistically significant.
Results
Baseline data
The mean age ± standard deviation of subjects was 22.3
± 1.0 years. The subjects’ height, body weight, and body
mass index were 158.0 ± 3.8 cm, 50.7 ± 4.6 kg, and 20.5
± 2.1 kg/m2, respectively. All subjects completed a meal
in approximately 15 min in each session. Table 1 shows
baseline data for physiological characteristics. There was
no difference in the baseline data.
Physiological responses
Changes in heart rate (HR) in the follicular phase are
shown in Fig. 2a. Two-way repeated-measures ANOVA
showed that time and meal condition had a signifi-
cant main effect on HR (time, P < 0.001, ηG
2 = 0.060;
meal, P < 0.001, ηG
2 = 0.118). There was also a signifi-
cant interaction effect between time and meal condi-
tion for HR (F [4, 24] = 6.34, P < 0.001, ηG
2 = 0.056).
Post-hoc testing showed that HR in the eating trial was
significantly increased at 20, 40, 60, and 80 min after the
meal compared with baseline (20 min, P = 0.026; 40 min,
P = 0.004; 60 min, P = 0.017; 80 min, P = 0.045). There
was no significant change in HR in the fasting trial. In
addition, HR was significantly higher in the eating trial
than in the fasting trial at 20, 40, 60, and 80 min after
the meal (20 min, P = 0.005; 40 min, P = 0.029; 60 min,
P < 0.001; 80 min, P = 0.005). Changes in HR in the
luteal phase are shown in Fig. 2b. Two-way repeated-
measures ANOVA showed that time and meal condi-
tion had a significant main effect on HR (time, P =
0.002, ηG
2 = 0.039; meal, P = 0.012, ηG
2 = 0.120). There
was also a significant interaction effect between time
and meal condition with HR (F [4, 24] = 5.79, P = 0.002,
ηG
2 = 0.030). Post-hoc testing showed that HR in the
eating trial was significantly increased at 20, 60, and
80 min after the meal compared with baseline (20 min,
P = 0.014; 60 min, P = 0.037; 80 min, P = 0.034). HR in
the fasting trial was significantly higher at 80 min after
the meal compared with 20 min after the meal (P =
0.029). In addition, HR was significantly higher in the
eating trial than in the fasting trial at 20, 40, and
60 min after the meal (20 min, P = 0.001; 40 min, P =
0.009; 60 min, P = 0.025).
Changes in SBP in the follicular and luteal phases are
shown in Fig. 3a and b. There was no significant main
effect or interaction effect for SBP.
Changes in DBP in the follicular phase are shown in
Fig. 4a. Two-way repeated-measures ANOVA showed that
time had a significant main effect on DBP (P = 0.03, ηG
2 =
0.019). There was also a significant interaction effect be-
tween time and meal condition for DBP (F [4, 24] = 5.48,
P = 0.003, ηG
2 = 0.058). Post-hoc testing showed that DBP
was significantly higher in the fasting trial than in the
eating trial at 40, 60, and 80 min after the meal
(40 min, P = 0.014; 60 min, P = 0.049; 80 min, P = 0.03).
Changes in DBP in the luteal phase are shown in Fig. 4b.
Two-way repeated-measures ANOVA showed that
time had a significant main effect on DBP (P = 0.037,
ηG
2 = 0.040). There was no significant interaction effect be-
tween time and meal condition for DBP. Post-hoc testing
showed that DBP was significantly higher in the fasting
trial than in the eating trial at 40 min after the meal.
HRV
Changes in the LF/HF ratio in the follicular and luteal
phases are shown in Fig. 5a and b. Two-way repeated-
measures ANOVA showed that meal condition had a
significant main effect on the LF/HF ratio in the luteal
phase (P = 0.038, ηG
2 = 0.095). Post-hoc testing showed
that the LF/HF ratio was significantly higher in the eat-
ing trial than in the fasting trial at 60 min after the meal
(P = 0.015). There were no other main or interaction ef-
fects for the LF/HF ratio.
Changes in HF power in the follicular phase are shown
in Fig. 6a. Two-way repeated-measures ANOVA showed
Table 1 Physiological characteristics at baseline in each trial
(n = 7)
Follicular phase Luteal phase
Fasting trial Eating trial Fasting trial Eating trial
HR (beats/min) 58.1 ± 8.1 56.3 ± 6.5 59.7 ± 9.2 60.9 ± 12.8
SBP (mmHg) 98.7 ± 13.9 100.4 ± 10.6 97.6 ± 9.4 101.4 ± 8.3
DBP (mmHg) 59.9 ± 9.1 62.5 ± 8.2 60.1 ± 7.4 60.1 ± 6.2
HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure
Data are mean ± standard deviation
There was no difference in baseline characteristics
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that meal condition had a significant main effect on HF
power in the follicular phase (P = 0.047, ηG
2 = 0.088). There
was also a significant interaction effect between time and
meal condition for HF (F [4, 24] = 2.83, P = 0.047, ηG
2 =
0.061). Post-hoc testing showed that HF power was signifi-
cantly higher in the fasting trial than in the eating trial at
60 and 80 min after the meal (60 min, P = 0.038; 80 min,
P = 0.018). Changes in HF power in the luteal phase are
shown in Fig. 6b. Two-way repeated-measures ANOVA
showed that time had a significant main effect on HF
power in the luteal phase (P = 0.042, ηG
2 = 0.060). There
was also a significant interaction effect between time and




Changes in salivary cortisol concentrations in the follicu-
lar phase are shown in Fig. 7a. Two-way repeated-
measures ANOVA showed that time had a significant
main effect on salivary cortisol concentrations in the
follicular phase (P = 0.003, ηG
2 = 0.065). There were no
other main or interaction effects in salivary cortisol
concentrations. Changes in salivary cortisol concentra-
tions in the luteal phase are shown in Fig. 7b. Two-way
repeated-measures ANOVA showed that time and meal
condition had a significant main effect on salivary cor-
tisol concentrations (time, P = 0.015, ηG
2 = 0.176; meal,
P = 0.028, ηG
2 = 0.319). There was also a significant inter-
action effect between time and meal condition for salivary
Fig. 2 Changes in heart rate (HR). a Follicular phase. b Luteal phase. The eating trial is shown by closed circles (●; n = 7) and the fasting trial is
shown by open circles (○;n = 7). *P < 0.05, comparison between time points in the eating or fasting session; †P < 0.05, comparison between the
eating and fasting trials
Fig. 3 Changes in systolic blood pressure (SBP). a Follicular phase. b Luteal phase. The eating trial is shown by closed circles (●; n = 7) and the
fasting trial is shown by open circles (○; n = 7)
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cortisol concentrations (F [4, 24] = 3.45, P = 0.023, ηG
2 =
0.066). Post-hoc testing showed that salivary cortisol con-
centrations were significantly higher in the eating trial than
in the fasting trial at 20, 40, and 80 min after the meal
(20 min, P = 0.011; 40 min, P = 0.011; 80 min, P = 0.037).
Discussion
In the present study, we evaluated the cardiovascular re-
sponse to the short-term fasting in the different men-
strual phases. The main results were as follows: (1) HR
was decreased during fasting in the follicular and luteal
phases; (2) HF power was increased during fasting in
the follicular and luteal phases; and (3) salivary cortisol
concentrations were decreased during fasting in the lu-
teal phase.
In the present study, during fasting, HR was decreased
and HF power was increased in the follicular and luteal
phases. Generally, HF power indicates parasympathetic
activity [25]. In addition, HR increases in the sympa-
thetic dominant phase and decreases in the parasympa-
thetic dominant phase [47]. Therefore, the present
results in the fasting state indicated that parasympathetic
activity was dominant. In male subjects, 12-h fasting re-
sults in dominance of parasympathetic activity compared
with food intake [37]. Conversely, little is known about
the effects of short-term fasting such as 12-h fasting in
women. Herbert et al. reported that 24 h of fasting in-
duced higher heart rate, and lower HF, indicating in-
creased sympathetic nervous system activity [48]. In
addition, 72-h fasting increased norepinephrine, dopa-
mine, and heart rate, and decreased cardiac vagal
Fig. 4 Changes in diastolic blood pressure (DBP). a Follicular phase. b Luteal phase. The eating trial is shown by closed circles (●; n = 7) and the
fasting trial is shown by open circles (○; n = 7). †P < 0.05, comparison between the eating and fasting trials
Fig. 5 Changes in low frequency/high frequency ratio (LF/HF). a Follicular phase. b Luteal phase. The eating trial is shown by closed circles
(●; n = 7) and the fasting trial is shown by open circles (○; n = 7). †P < 0.05, comparison between the eating and fasting trials
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modulation [49]. These results are inconsistent with our
results. The reason for this discrepancy is unclear, but it
may be a result of the difference in fasting duration.
In our study, interestingly, salivary cortisol concentra-
tions were decreased during fasting in the luteal phase.
Salivary cortisol is reflected by stressful situations. Corti-
sol concentrations increase during stressful situations
and decrease during low-stress situations [50]. The use
of a potent laboratory stress protocol reproducing a job
interview (e.g., the Trier Social Stress Test [51]) activates
the sympathetic–adrenomedullary system and the hypo-
thalamic–pituitary–adrenocortical axis [52]. Both sys-
tems interact in managing the adaptive response to
stressful events, and biomarkers of these systems can be
evaluated non-invasively in saliva. This method allows
repeated samples in a short time [53–55]. Activation of
the hypothalamic–pituitary–adrenocortical axis induces
the secretion of cortisol, which stimulates mobilization of
the energy required to overcome the stressor. Therefore,
cortisol is considered as the main biomarker in stress
research [50]. Based on these facts, the present results
indicate that fasting leads to less stressful conditions.
These results are consistent with the present results of
HR or autonomic activity. Reduction of stress has also
been shown in previous reports in some experiments in
rats or rhesus monkeys [56, 57] and men [37], but not
in women. Interestingly, in the present study, anti-
stress effects were shown in female subjects in the
luteal phase. This suggests that DR has an anti-stress
effect on the luteal phase. Menstrual cycle-related
symptoms are severe during the luteal phase [58], and
stress is related to these symptoms [23]. Therefore, DR
is also expected to reduce these symptoms and increase
quality of life in women.
Fig. 6 Changes in high frequency (HF). a Follicular phase. b Luteal phase. The eating trial is shown by closed circles (●; n = 7) and the fasting trial
is shown by open circles (○; n = 7). †P < 0.05, comparison between the eating and fasting trials
Fig. 7 Changes in salivary cortisol concentrations. a Follicular phase. b Luteal phase. The eating trial is shown by closed circles (●; n = 7) and the
fasting trial is shown by open circles (○; n = 7). †P < 0.05, comparison between the eating and fasting trials
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Limitations
There are some limitations to this study. First, the meals
used in the present study had a complicated nutrient
content, whereas fasting was a simple experiment.
Therefore, the underlying mechanism for the present re-
sults is still unclear. The autonomic nervous system en-
gages in maintenance of homeostasis by cooperation
with other regulatory systems. Therefore, the underlying
mechanism in this study may be explained from the
viewpoint of whole-body coordination in future studies.
Second, we conducted experiments with a controlled
setting, which may be different from a non-controlled
setting. Third, we did not investigate the long-term
effects of fasting. Long-term effects of food intake are
ultimately necessary to clarify the influence of daily life-
styles in humans. Therefore, further studies are required
to determine this issue. Fourth, the present study
does not refer to longer-term stress. Future studies need
to test repeated 12-h fasting to verify the effects of
fasting on long-term stress. Repeated 12-h fasting may
not only affect long-term stress but also address the
feasibility and safety of fasting, and the influence of
resumed eating on stress levels.
Conclusions
We evaluated the cardiovascular response to short-term
fasting in each menstrual phase in healthy young fe-
males. HR is decreased during fasting in the follicular
and luteal phases. HF power is increased during fasting
in the follicular and luteal phases. Additionally, salivary
cortisol concentrations are decreased during fasting in
the luteal phase. These results suggest a possibility of
short-term fasting to produce anti-stress effects in the
luteal phase in women, which may lead to reduced men-
strual symptoms. Twelve-hour fasting is an easy method
to practice in daily life without help from a health pro-
fessional. To that end, further study needs to clarify the
mechanisms underlying these findings and to verify the
long-term effects of fasting.
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